Keywords:
Hirschsprung’s disease; postoperative enterocolitis; children; immunological determinants; innate immunity; mucosal immunity; cytokines; risk predictionReferences
Austin K.M. The pathogenesis of Hirschsprung-associated enterocolitis. Seminars in Pediatric Surgery. 2012;21(4):319–327.
Bachmann L., et al. Altered mucosal immunity and bacterial translocation in Hirschsprung disease. Journal of Pediatric Surgery. 2019;54(6):1171–1177.
Calleja E., et al. Cytokine imbalance and intestinal inflammation in Hirschsprung-associated enterocolitis. Pediatric Surgery International. 2018;34(9):959–966.
De la Torre L., et al. Hirschsprung disease and enterocolitis: Pathophysiology and prevention. World Journal of Gastroenterology. 2016;22(1):1–10.
Elhalaby E.A., et al. Immunological and histopathological changes in Hirschsprung-associated enterocolitis. Journal of Pediatric Gastroenterology and Nutrition. 2015;60(2):203–209.
Frykman P.K., et al. Toll-like receptor signaling and innate immunity in Hirschsprung disease. Pediatric Research. 2017;81(2):250–257.
Gosain A., et al. Established and emerging concepts in Hirschsprung-associated enterocolitis. Pediatric Surgery International. 2018;34(9):897–905.
Lehtonen L., et al. Secretory IgA deficiency and intestinal barrier dysfunction in pediatric intestinal diseases. Clinical Immunology. 2014;152(1–2):70–78.
Neuvonen M.I., et al. Intestinal permeability and zonulin expression in pediatric inflam-matory bowel conditions. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(4):514–520.
Zani A., et al. Immune dysregulation in Hirschsprung-associated enterocolitis: Clinical implications. Seminars in Pediatric Surgery. 2017;26(5):328–335.